Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2025-12-25 @ 12:13 AM
NCT ID:
NCT01800058
Eligibility Criteria:
Inclusion Criteria:
* Patients aged \> 18 with capacity to give informed consent.
* Patients with histologically confirmed prostate cancer.
* Patients with a high risk factor: PSA\> 20 ng / ml, Gleason 8-10 and / or stage T3a-b, N0M0 (NCCN 2011, stage IIB-III AJCC classification 2010). Staging by: Histology-Gleason score-, PSA, TR, ECO TR, CT, MRI.
* Patients who accept radical treatment with radiotherapy.
* Patients who give written informed consent to participate in the study
Exclusion Criteria:
* Any patient diagnosed with prostate cancer, which does not meet the prerequisites.
* Any patients with another malignancy diagnosed in the past 5 years (except basal cell or squamous cell carcinoma of skin).
* Any patient who has prostate biopsy performed 7 days prior to study entry.
* Patients who have received prior treatment with hormonal therapy, chemotherapy or radiotherapy.
* Patients with PSA\> 100 ng / ml.
* Any situation or condition of the patient which in the opinion of the investigator, advised against participation in the study.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT01800058
Study Brief:
Protocol Section:
NCT01800058